Millennium Pharmaceuticals Inc. / COR Therapeutics Inc.
2002 · Acquisition/Merger · $2.0B · Complete
Announcement Sentiment
50
Neutral / mixed
Announced Dec 6, 2001; closed February 12, 2002. Stock-for-stock $2B. Brought Integrilin (eptifibatide) and cardiovascular franchise. Tier 2 (SEC) verified.